Literature DB >> 32332072

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.

Alexis Mathian1, Matthieu Mahevas2, Julien Rohmer3, Mathilde Roumier3, Fleur Cohen-Aubart4, Blanca Amador-Borrero5, Audrey Barrelet6, Cecile Chauvet7, Thibaud Chazal4, Michel Delahousse8, Mathilde Devaux9, Romain Euvrard10, Jehane Fadlallah4, Nans Florens11, Julien Haroche4, Miguel Hié4, Laurent Juillard11, Raphael Lhote4,12, Thibault Maillet13, Gaelle Richard-Colmant14, Jean Baptiste Palluy10, Micheline Pha4, Laurent Perard15, Philippe Remy16, Etienne Rivière17, Damien Sène5, Pascal Sève14, Capucine Morélot-Panzini18, Jean-François Viallard17, Jean-Simon Virot19, Neila Benameur20, Noël Zahr21, Hans Yssel22, Bertrand Godeau2, Zahir Amoura4.   

Abstract

Entities:  

Keywords:  hydroxychloroquine; lupus erythematosus, systemic; lupus nephritis

Mesh：

Substances：

Year:  2020        PMID： 32332072     DOI： 10.1136/annrheumdis-2020-217566

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   27.973


× No keyword cloud information.
  65 in total

1.  COVID-19 in Patients With Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and Disease-Modifying Antirheumatic Drugs on Clinical Outcomes.

Authors:  Rebecca H Haberman; Rochelle Castillo; Alan Chen; Di Yan; Deborah Ramirez; Vaish Sekar; Robert Lesser; Gary Solomon; Andrea L Neimann; Rebecca B Blank; Peter Izmirly; Dan E Webster; Alexis Ogdie; Andrea B Troxel; Samrachana Adhikari; Jose U Scher
Journal:  Arthritis Rheumatol       Date:  2020-10-25       Impact factor: 10.995

2.  Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence.

Authors:  Konstantinos Tselios; Panagiotis Skendros
Journal:  Eur J Rheumatol       Date:  2020-05-15

Review 3.  Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management.

Authors:  Pankti Mehta; Armen Yuri Gasparyan; Olena Zimba; George D Kitas
Journal:  Clin Rheumatol       Date:  2022-05-31       Impact factor: 3.650

4.  Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.

Authors:  Maximilian F Konig; Alfred Hj Kim; Marc H Scheetz; Elizabeth R Graef; Jean W Liew; Julia Simard; Pedro M Machado; Milena Gianfrancesco; Jinoos Yazdany; Daman Langguth; Philip C Robinson
Journal:  Ann Rheum Dis       Date:  2020-05-07       Impact factor: 19.103

5.  Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry.

Authors:  María Del Mar Ayala Gutiérrez; Manuel Rubio-Rivas; Carlos Romero Gómez; Abelardo Montero Sáez; Iván Pérez de Pedro; Narcís Homs; Blanca Ayuso García; Carmen Cuenca Carvajal; Francisco Arnalich Fernández; José Luis Beato Pérez; Juan Antonio Vargas Núñez; Laura Letona Giménez; Carmen Suárez Fernández; Manuel Méndez Bailón; Carlota Tuñón de Almeida; Julio González Moraleja; Mayte de Guzmán García-Monge; Cristina Helguera Amezua; María Del Pilar Fidalgo Montero; Vicente Giner Galvañ; Ricardo Gil Sánchez; Jorge Collado Sáenz; Ramon Boixeda; José Manuel Ramos Rincón; Ricardo Gómez Huelgas
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

6.  Correlation of Coagulation Parameters With Clinical Outcomes During the Coronavirus-19 Surge in New York: Observational Cohort.

Authors:  Morayma Reyes Gil; Jesus D Gonzalez-Lugo; Shafia Rahman; Mohammad Barouqa; James Szymanski; Kenji Ikemura; Yungtai Lo; Henny H Billett
Journal:  Front Physiol       Date:  2021-02-23       Impact factor: 4.566

Review 7.  Hydroxychloroquine: A review of its safety and efficacy in COVID-19.

Authors:  Rutu H Karia; Sanjana Nagraj; Ishita Gupta; Amit Barua; Nirmaljot Kaur; Harmandeep Singh
Journal:  J Family Med Prim Care       Date:  2021-04-08

8.  Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort.

Authors:  Amit Saxena; Allison Guttmann; Mala Masson; Mimi Y Kim; Rebecca H Haberman; Rochelle Castillo; Jose U Scher; Kristina K Deonaraine; Alexis J Engel; H Michael Belmont; Ashira D Blazer; Jill P Buyon; Ruth Fernandez-Ruiz; Peter M Izmirly
Journal:  Lancet Rheumatol       Date:  2021-05-27

Review 9.  Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients.

Authors:  Serena Colafrancesco; Rossana Scrivo; Cristiana Barbati; Fabrizio Conti; Roberta Priori
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

10.  Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.

Authors:  Rocío-V Gamboa-Cárdenas; Silvia Barzola-Cerrón; Denisse Toledo-Neira; Cristina Reátegui-Sokolova; Víctor Pimentel-Quiroz; Francisco Zevallos-Miranda; Graciela S Alarcón; Manuel Ugarte-Gil
Journal:  Clin Rheumatol       Date:  2021-06-30       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.